Lunit to Supply Chest X-Ray and Mammography AI to Saudi National Guard Health System

The agreement covers Lunit INSIGHT CXR, which analyses chest X-rays, and Lunit INSIGHT MMG, which reads mammograms. Lunit will provide the software licences. Solutions by stc, the information and communications technology subsidiary of stc Group, will be the systems integrator.

Both tools will be connected to MNGHA's existing picture archiving and communication system (PACS), the software hospitals use to store and view medical images. That means clinicians will see the AI findings inside the imaging workflow they already use, not in a separate application. For hospital AI vendors, this kind of integration with established clinical systems often decides whether a tool moves beyond a pilot and is used every day.

The release did not disclose the value or length of the contract, how many facilities or licences it covers, or when the systems will go live.

MNGHA was set up in 1982 under Saudi Arabia's Ministry of National Guard. It treats National Guard personnel, their families and members of the public through a network of hospitals and medical centres, with major facilities in Riyadh and Jeddah. According to Lunit, one of those facilities, King Abdulaziz Medical City in Riyadh, became in 2022 the first healthcare institution in the world to reach Stage 7 on four HIMSS digital maturity models. HIMSS is a health information technology body whose scales measure how fully a hospital has digitised its records and clinical processes.

Lunit has been working in Saudi Arabia for several years. In 2023 it took part in programmes with SEHA Virtual Hospital and the Healthcare Sandbox, both linked to the digital health goals of Vision 2030. In the same year it agreed to supply the same two products, INSIGHT CXR and INSIGHT MMG, to Dr. Sulaiman Al Habib Medical Group, one of the kingdom's large private hospital operators. The MNGHA contract extends that footprint into the government health sector.

Chief executive Brandon Suh said the deployment showed "the capabilities of our AI solutions" and their ability to work inside large healthcare systems. He said Lunit wants to strengthen its presence in Saudi Arabia and widen access to "AI-powered cancer screening across the Middle East."

Lunit was founded in 2013 and is based in Seoul. Its shares trade on the Korea Exchange. Its products cover medical imaging, breast health and biomarker analysis, including the Lunit INSIGHT Breast Suite, which is cleared by the US Food and Drug Administration, and the Lunit SCOPE platform for biomarker research. The company says its products are used at more than 10,000 sites in more than 65 countries.

The company has not said when the tools will start running in MNGHA hospitals.